Severe, Persistent, Disruptive Fatigue Post-SARS-CoV-2 Disproportionately Affects Young Women

References

• Ledford H. How common is long COVID? Why studies give different answers. Nature. 2022;606(7916):852–853. doi:10.1038/d41586-022-01702-2
   PubMed Web of Science ®Google Scholar
• Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterization of post-COVID-19 manifestations. Int J Clin Pract. 2021;75(3):e13746. doi:10.1111/ijcp.13746
   PubMed Web of Science ®Google Scholar
• Carter SJ, Baranauskas MN, Raglin JS, Pescosolido BA, Perry BL. Functional status, mood state, and physical activity among women with post-acute COVID-19 syndrome. Int J Public Health. 2022;67:1604589. doi:10.3389/ijph.2022.1604589
   PubMed Web of Science ®Google Scholar
• Munipalli B, Seim L, Dawson NL, Knight D, Dabrh AMA. Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and management. SN Compr Clin Med. 2022;4(1):90. doi:10.1007/s42399-022-01167-4
   PubMedGoogle Scholar
• Chippa V, Aleem A, Anjum F. Post-Acute Coronavirus (COVID-19) Syndrome. Treasure Island (FL): StatPearls Publishing; 2023.
   Google Scholar
• Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626–631. doi:10.1038/s41591-021-01292-y
   PubMed Web of Science ®Google Scholar
• Jacobs LG, Paleoudis EG, Lesky-di bari D, et al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS One. 2020;15(12):e0243882. doi:10.1371/journal.pone.0243882
   PubMed Web of Science ®Google Scholar
• Subramanian A, Nirantharakumar K, Hughes S. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28(8):1706–1714. doi:10.1038/s41591-022-01909-w
   PubMed Web of Science ®Google Scholar
• National Center for Health Statistics. U.S. Census Bureau, Household Pulse Survey, 2022–2023. Long COVID. [Internet, generated interactively] Available from: https://www.cdc.gov/nchs/covid19/pulse/long-covid.htm. Accessed June 12, 2023.
   Google Scholar
• Qasmieh SA, Robertson MM, Teasdale CA, et al. The prevalence of SARS-CoV-2 infection and long COVID in U.S. adults during the BA.4/BA.5 surge, June-July 2022. Prev Med. 2023;169:107461. doi:10.1016/j.ypmed.2023.107461
   PubMed Web of Science ®Google Scholar
• O’Mahoney LL, Routen A, Gillies C, et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine. 2022;55:101762. doi:10.1016/j.eclinm.2022.101762
   PubMedGoogle Scholar
• de Avila L, Price JK, Stepanova M, et al. Regular exercise is associated with low fatigue levels and good functional outcomes Post-COVID-19: a prospective observational study. Am J Phys Med Rehabil. 2023;102(5):433–443. doi:10.1097/PHM.0000000000002197
   PubMed Web of Science ®Google Scholar
• Malik P, Patel K, Pinto C, et al. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-A systematic review and meta-analysis. J Med Virol. 2022;94(1):253–262. doi:10.1002/jmv.27309
   PubMed Web of Science ®Google Scholar
• Ayoubkhani D, Bosworth ML, King S, et al. Risk of long COVID in people infected with severe acute respiratory syndrome coronavirus 2 after 2 doses of a coronavirus disease 2019 vaccine: community-based, matched cohort study. Open Forum Infect Dis. 2022;9(9):ofac464. doi:10.1093/ofid/ofac464
   PubMed Web of Science ®Google Scholar
• NIH. NIH RECOVER research identifies potential long COVID disparities. Available from: https://www.nih.gov/news-events/news-releases/nih-recover-research-identifies-potential-long-covid-disparities. Accessed June 12, 2023.
   Google Scholar
• Pfaff ER, Madlock-Brown C, Baratta JM, et al. N3C Consortium; RECOVER Consortium. Coding long COVID: characterizing a new disease through an ICD-10 lens. BMC Med. 2023;21(1):58. doi:10.1186/s12916-023-02737-6
   PubMedGoogle Scholar
• Khullar D, Zhang Y, Zang C, et al. Racial/ethnic disparities in post-acute sequelae of SARS-CoV-2 infection in New York: an EHR-based cohort study from the RECOVER Program. J Gen Intern Med. 2023;38:1127–1136. doi:10.1007/s11606-022-07997-1
   PubMed Web of Science ®Google Scholar
• Yoo SM, Liu TC, Motwani Y, et al. Factors associated with post-acute sequelae of SARS-CoV-2 (PASC) after diagnosis of symptomatic COVID-19 in the inpatient and outpatient setting in a diverse cohort. J Gen Intern Med. 2022;37(8):1988–1995. doi:10.1007/s11606-022-07523-3
   PubMed Web of Science ®Google Scholar
• Price JK, Gerber LH, Stepanova M, et al. Post-acute SARS-CoV-2 symptoms are fewer, less intense over time in people treated with mono-clonal antibodies for acute infection. Int J Gen Med. 2023;16:1479–1490. doi:10.2147/IJGM.S406571
   PubMed Web of Science ®Google Scholar
• Mannan A, Sutingco N, Djurkovic S, et al. Service line care delivery model for COVID-19 patient-centric care. Am J Manag Care. 2022;28(3):e80–e87. doi:10.37765/ajmc.2022.88731
   PubMed Web of Science ®Google Scholar
• Verderese JP, Stepanova M, Lam BP. Neutralizing monoclonal antibody treatment reduces hospitalization for mild and moderate coronavirus disease 2019 (COVID-19): a real-world experience. Clin Infect Dis. 2022;74(6):1063–1069. doi:10.1093/cid/ciab579
   PubMed Web of Science ®Google Scholar
• Stepanova M, Lam BP, Younossi E, et al. The impact of variants and vaccination on the mortality and resource utilization of hospitalized patients with COVID-19. BMC Infect Dis. 2022;22(1):702. doi:10.1186/s12879-022-07657-z
   PubMed Web of Science ®Google Scholar
• Lam BP, Stepanova M, Venkatesan C, et al. Outcomes of hospitalized patients with COVID-19 during the course of the pandemic in a fully integrated health system. PLoS One. 2022;17(2):e0263417. doi:10.1371/journal.pone.0263417
   PubMed Web of Science ®Google Scholar
• Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133–146. doi:10.1038/s41579-022-00846-2
   PubMed Web of Science ®Google Scholar
• Priyanka CH, Choudhary OP. mRNA vaccines as an armor to combat the infectious diseases. Travel Med Infect Dis. 2023;52:102550. doi:10.1016/j.tmaid.2023.102550
   PubMed Web of Science ®Google Scholar
• Dhawan M, Parmar M, Angural S. Convalescent plasma therapy against the emerging SARS-CoV-2 variants: delineation of the potentialities and risks. Int J Surg. 2022;97:106204. doi:10.1016/j.ijsu.2021.106204
   PubMed Web of Science ®Google Scholar
• Maya S, Kahn JG, Lin TK, et al. Indirect COVID-19 health effects and potential mitigating interventions: cost-effectiveness framework. PLoS One. 2022;17(7):e0271523. doi:10.1371/journal.pone.0271523
   PubMed Web of Science ®Google Scholar
• Lung. Learn about shortness of breath. Available from: https://www.lung.org/lung-health-diseases/warning-signs-of-lung-disease/shortness-of-breath/learn-about-shortness-of-breath. Accessed June 12, 2023.
   Google Scholar
• NHS Inform. Shortness of breath. Available from: https://www.nhsinform.scot/illnesses-and-conditions/lungs-and-airways/shortness-of-breath. Accessed June 12, 2023.
   Google Scholar
• Rasa S, Nora-Krukle Z, Henning N, et al. European Network on ME/CFS (EUROMENE). Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Transl Med. 2018;16(1):268. doi:10.1186/s12967-018-1644-y
   PubMedGoogle Scholar
• Price J, Escheik C, Azim Y, et al. Sustained virologic response (SVR) in hepatitis C (HCV) patients does not demonstrate differences in physical performance, fatigue, sleep, and health-related quality of life (HRQL). Am J Gastroenterol. 2013;108:S122. doi:10.14309/00000434-201310001-00410
   Web of Science ®Google Scholar
• Monaghan AM. An examination of physical activity, cardiorespiratory fitness and cardio-metabolic health through the modern hepatitis C continuum, Trinity College Dublin. School of Medicine. 2019.
   Google Scholar
• Cortes Rivera M, Mastronardi C, Silva-Aldana CT, Arcos-Burgos M, Lidbury BA. Myalgic encephalomyelitis/chronic fatigue syndrome: a comprehensive review. Diagnostics. 2019;9(3):91. doi:10.3390/diagnostics9030091
   Web of Science ®Google Scholar
• Weinstein AA, Escheik C, Oe B, Price JK, Gerber LH, Younossi ZM. Perception of effort during activity in patients with chronic hepatitis C and nonalcoholic fatty liver disease. Pm&r. 2016;8(1):28–34. doi:10.1016/j.pmrj.2015.06.001
   Web of Science ®Google Scholar
• Austin P, Gerber L, Paik JM, Price JK, Escheik C, Younossi ZM. Aerobic capacity and exercise performance in nonalcoholic fatty liver disease. J Sports Med Phys Fitness. 2019;59(8):1376–1388. doi:10.23736/S0022-4707.19.09231-4
   PubMed Web of Science ®Google Scholar
• Gerber L, Estep M, Stepanova M, Escheik C, Weinstein A, Younossi ZM. Effects of viral eradication with ledipasvir and sofosbuvir, with or without ribavirin, on measures of fatigue in patients with chronic hepatitis C virus infection. Clin Gastroenterol Hepatol. 2016;14(1):156–164.e3. doi:10.1016/j.cgh.2015.07.035
   PubMed Web of Science ®Google Scholar
• Twomey R, DeMars J, Franklin K, Culos-Reed SN, Weatherald J, Wrightson JG. Chronic fatigue and post exertional malaise in people living with long COVID: an observational study. Phys Ther. 2022;102(4):zac005. doi:10.1093/ptj/pzac005
   Web of Science ®Google Scholar
• Webster K, Cella D, Yost K. The functional assessment of chronic illness therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual Life Outcomes. 2003;1(79):1–7. doi:10.1186/1477-7525-1-79
   PubMedGoogle Scholar